BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21692032)

  • 1. Myeloid CD11c+ S100+ dendritic cells express indoleamine 2,3-dioxygenase at the inflammatory border to invasive lower lip squamous cell carcinoma.
    Kuales MA; Wenzel J; Schmid-Wendtner MH; Bieber T; von Bubnoff D
    Histol Histopathol; 2011 Aug; 26(8):997-1006. PubMed ID: 21692032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoleamine 2,3-dioxygenase expression in early keratocyte neoplasia of the lower lip correlates to the degree of cell atypia.
    von Bubnoff D; Zahn S; Wenzel J; Wilms H; Bieber T; Lüftl M
    Pathol Int; 2012 Feb; 62(2):105-11. PubMed ID: 22243780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indoleamine 2,3-dioxygenase-expressing myeloid dendritic cells and macrophages in infectious and noninfectious cutaneous granulomas.
    von Bubnoff D; Scheler M; Wilms H; Wenzel J; von Bubnoff N; Häcker G; Schultze J; Popov A; Racz P; Bieber T; Wickenhauser C
    J Am Acad Dermatol; 2011 Oct; 65(4):819-832. PubMed ID: 21501890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of indoleamine 2,3-dioxygenase in human esophageal squamous cell carcinomas.
    Liu J; Lu G; Tang F; Liu Y; Cui G
    Virchows Arch; 2009 Nov; 455(5):441-8. PubMed ID: 19844741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indoleamine 2,3-dioxygenase (IDO): the antagonist of type I interferon-driven skin inflammation?
    Scheler M; Wenzel J; Tüting T; Takikawa O; Bieber T; von Bubnoff D
    Am J Pathol; 2007 Dec; 171(6):1936-43. PubMed ID: 18055547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.
    Yen MC; Lin CC; Chen YL; Huang SS; Yang HJ; Chang CP; Lei HY; Lai MD
    Clin Cancer Res; 2009 Jan; 15(2):641-9. PubMed ID: 19147770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression.
    Wobser M; Voigt H; Houben R; Eggert AO; Freiwald M; Kaemmerer U; Kaempgen E; Schrama D; Becker JC
    Cancer Immunol Immunother; 2007 Jul; 56(7):1017-24. PubMed ID: 17195079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-L1 and IDO expression in cervical and vulvar invasive and intraepithelial squamous neoplasias: implications for combination immunotherapy.
    Chinn Z; Stoler MH; Mills AM
    Histopathology; 2019 Jan; 74(2):256-268. PubMed ID: 30067880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients.
    Roy S; Barik S; Banerjee S; Bhuniya A; Pal S; Basu P; Biswas J; Goswami S; Chakraborty T; Bose A; Baral R
    Hum Immunol; 2013 Aug; 74(8):1015-23. PubMed ID: 23628394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosmarinic acid inhibits indoleamine 2,3-dioxygenase expression in murine dendritic cells.
    Lee HJ; Jeong YI; Lee TH; Jung ID; Lee JS; Lee CM; Kim JI; Joo H; Lee JD; Park YM
    Biochem Pharmacol; 2007 May; 73(9):1412-21. PubMed ID: 17229401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.
    Kahler DJ; Mellor AL
    Handb Exp Pharmacol; 2009; (188):165-96. PubMed ID: 19031026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia.
    Xu SQ; Wang CY; Zhu XJ; Dong XY; Shi Y; Peng J; Qin P; Sun JZ; Guo C; Ni H; Hou M
    Ann Hematol; 2012 Oct; 91(10):1623-31. PubMed ID: 22526360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.
    Sharma MD; Baban B; Chandler P; Hou DY; Singh N; Yagita H; Azuma M; Blazar BR; Mellor AL; Munn DH
    J Clin Invest; 2007 Sep; 117(9):2570-82. PubMed ID: 17710230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression and prognostic relevance of indoleamine 2,3-dioxygenase in tongue squamous cell carcinoma.
    Seppälä M; Halme E; Tiilikainen L; Luukkainen A; Laranne J; Rautiainen M; Huhtala H; Paavonen T; Toppila-Salmi S
    Acta Otolaryngol; 2016 Jul; 136(7):729-35. PubMed ID: 26982018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity uptake of kynurenine and nitric oxide-mediated inhibition of indoleamine 2,3-dioxygenase in bone marrow-derived myeloid dendritic cells.
    Hara T; Ogasawara N; Akimoto H; Takikawa O; Hiramatsu R; Kawabe T; Isobe K; Nagase F
    Immunol Lett; 2008 Feb; 116(1):95-102. PubMed ID: 18179826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma.
    Han Y; Chen Z; Yang Y; Jiang Z; Gu Y; Liu Y; Lin C; Pan Z; Yu Y; Jiang M; Zhou W; Cao X
    Hepatology; 2014 Feb; 59(2):567-79. PubMed ID: 23960017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.
    Munn DH; Sharma MD; Hou D; Baban B; Lee JR; Antonia SJ; Messina JL; Chandler P; Koni PA; Mellor AL
    J Clin Invest; 2004 Jul; 114(2):280-90. PubMed ID: 15254595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumoral indoleamine 2,3-dioxygenase expression predicts poor outcome in laryngeal squamous cell carcinoma.
    Ye J; Liu H; Hu Y; Li P; Zhang G; Li Y
    Virchows Arch; 2013 Jan; 462(1):73-81. PubMed ID: 23179760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immature dendritic cells expressing indoleamine 2,3-dioxygenase suppress ovalbumin-induced allergic airway inflammation in mice.
    An XJ; Bai CX; Xia JB; Dang T; Qian P; Qian GS; Liao W
    J Investig Allergol Clin Immunol; 2011; 21(3):185-92. PubMed ID: 21548446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoleamine 2,3-Dioxygenase Expression in Primary Cutaneous Melanoma Correlates with Breslow Thickness and Is of Significant Prognostic Value for Progression-Free Survival.
    Rubel F; Kern JS; Technau-Hafsi K; Uhrich S; Thoma K; Häcker G; von Bubnoff N; Meiss F; von Bubnoff D
    J Invest Dermatol; 2018 Mar; 138(3):679-687. PubMed ID: 29054599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.